" "

Infectious disease testing system and assays

Infectious disease testing system and assays

Abbott has announced CE Mark for the Alinity m diagnostic system and assays that will allow laboratories to meet the growing demand for infectious disease testing by offering increased efficiency, speed...

Supplied by Abbott Diagnostics Europe


Abbott has announced CE Mark for the Alinity m diagnostic system and assays that will allow laboratories to meet the growing demand for infectious disease testing by offering increased efficiency, speed and accuracy. This new technology will provide high flexibility in molecular diagnostic testing, allowing more tests to be done in shorter timeframes, while reducing the space and number of instruments needed to conduct large amounts of tests. The World Health Organization (WHO) reports that more than a billion people around the world are living with infectious diseases. For people living with infectious diseases, quick and accurate molecular test results are needed to help prevent the spread of communicable diseases globally. Advanced molecular testing also allows patients to be diagnosed correctly and then monitored for their response to treatment. Molecular laboratories are playing an increasingly important role in providing critical test results for infectious disease diagnosis. Alinity m will significantly improve the way these laboratories operate by letting staff run any sample at any time, without the need to group samples, allowing them to focus on giving physicians the information they need to make accurate, timely clinical decisions. Alinity m provides superior flexibility for lab staff and faster testing results for clinicians and patients.  Alinity m may also reduce the lab equipment footprint from four to six instruments down to one – decreasing the space requirements and hours spent learning and maintaining different instruments. Now available in countries that recognize CE Mark, Alinity m offers initial assays including virologic testing for human immunodeficiency virus type 1 (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV); sexual health-related testing for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium or CT/NG/TV/MG panel; and high-risk human papillomavirus (HPV) testing. Local product availability may vary depending on geographic location.

ABBOTT


Contact form

Get in touch directly with the above supplier

Your email address will not be communicated to any third party other than the above supplier for the purpose of fulfilling this enquiry. For more information: read our privacy policy.

Other products from this supplier